HP&M’s Sophia Gaulkin to Present on Drug Pricing at Advanced Summit on Life Sciences Patents

Hyman, Phelps & McNamara, P.C. is pleased to announce that Sophia Gaulkin will be speaking on an expert panel at the 20th Advanced Summit on Life Sciences Patents, which is being held virtually and in-person in New York City on June 2-3, 2022.

Ms. Gaulkin will join speakers from the biopharmaceutical industry and academia to discuss the impact of drug pricing on patent prosecution in the session, Drug Price Regulation: What’s Patent Law Got to Do With It?  She will set the stage for the discussion by tracing the landscape of drug pricing legislation and other reform efforts at the state, federal, and international level and identify drug pricing considerations that patent prosecutors should consider in their practices. The panel will also cover the status of U.S. and global responses to escalating drug costs and access issues, including price controls, compulsory licensing, and the TRIPS waiver.

This hybrid event brings together thought leaders working in or with the life sciences patents industry to share best practices and discuss how recent cases and policy changes will impact fundamental patent law concepts.

FDA Law Blog readers are offered a discount of 10% off the registration price.  The discount code is S10-762-762L22.S.  You can access conference information and register for the event here.